Farms.com Home   Ag Industry News

Rollins Resets USDA Priorities with New Merit-Based Approach

Jul 11, 2025
By Farms.com

USDA Now Focuses on Fairness and Equal Opportunity

The U.S. Department of Agriculture, under Secretary Brooke Rollins, announces a major policy change by removing race and gender preferences from its programs. This decision ends practices that were not required by Congress and aims to make USDA programs fair and based on merit.

The rule change follows a federal court ruling that found the previous administration’s policies violated the Constitution by favoring applicants based on race and gender. No appeal was filed, confirming that the policy was unlawful.

From her first day in office, Secretary Rollins has worked to restore trust in USDA programs. She ordered a full review of how federal funds, including those from the Inflation Reduction Act, are used. Her goal is to ensure that all spending serves American farmers fairly and responsibly.

Secretary Rollins also directed the removal of all diversity, equity, and inclusion (DEI) programs within USDA. The department continues to review its policies to make sure that taxpayer dollars are spent in a way that supports agriculture without discrimination.

Leaders in the current administration believe that help for farmers should be based on need and merit—not on race or gender. By ending these rules, USDA is now working to treat all farmers equally.


Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.